Monday, November 20, 2017 9:12:46 PM
1. There is always a little bit of selling pressure (as if some vendors or employees get paid in shares), so if there are no buyers it will drip, possibly down to .01 or below, in the next 2-3 months.
2. There will be spikes. Sometimes it is manipulation, sometimes it's news, but THERE WILL BE SPIKES.
Up until this Sanofi project, people who got in at .02 were pretty eager to get out around .03 (myself included), but now the resistance HAS to be a little higher. I think it's reasonable to expect to be able to get out around .035 without waiting too long, if desired.
I'm completely out and I plan on getting back in under .015. The insiders aren't going to let this company die. They'll find a way to fund it and keep trying for that lucky payday.
But Sanofi can't possibly trust this little company now, IMO. They have to be thinking (a) these guys are clowns, or (b) the Slovay results were wrong or fraudulent and our results are correct. I have to believe that if Sanofi felt otherwise -- if they thought there was a (c) -- Sanofi would have paid the $125,000 to redo the tests.
In other words, it sure looks like Sanofi was ready to walk and Mymetics begged them "Please please please give us another chance, we'll pay for it, don't dump us!"
So, Astellas came courting and ran away, and now I believe Sanofi is just pretending to care. How many more White Knights are trotting around? Hope I'm wrong but I'm setting my sights low again as usual, meaning, get in at .015 and try to get out at .025 or maybe .03 on a check from Bill Gates or some other bit of news.
Best of luck to all who remain.
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM